BOEHRINGER INGELHEIM
“ IT USED TO BE ENOUGH FOR IT PEOPLE TO BE ON TOP OF TECHNOLOGY . NOW , YOU NEED EVERYBODY ON BOARD ”
BRUNO RIZZUTI HEAD OF DATA MANAGEMENT , BOEHRINGER INGELHEIM
Also in Vienna , the Biomarker-Based Patient Population project empowers experts within the company to identify biomarkers to better characterise patient populations for clinical studies . Being able to process and analyse large amounts of data creates the potential to select the right drug for a patient .
Based in Buenos Aires , Argentina , PetPro is one of the company ' s first digital products that directly addresses end users ’ needs . PetPro Connect has been developed in close collaboration with the company ' s Animal Health business to connect pet owners and veterinarians , organise follow-up appointments via video chat , quickly and easily order medication refills , and benefit from bonus programmes .
Over in Spain , the company ' s Pathological Speech Processing team – based in Sant Cugat del Vallés , Barcelona – develops digital tools that facilitate the process of speech and language processing ( SLP ) by using machine learning and disease-customised algorithms . This will be used to analyse speech and language patterns , which can consequently be analysed to predict the development of mental diseases , such as the risk of dementia .
More Health , More Potential and More Green at Boehringer Ingelheim Boehringer Ingelheim has defined three areas : More Health , More Potential and More Green – which are at the heart of a framework the company calls Sustainable Development For Generations . The framework incorporates established initiatives , building these into more ambitious goals to increase the company ’ s impact on health , society and the planet . In doing so , Boehringer Ingelheim generates greater long-term economic and social value for stakeholders , the communities they serve and employees .
Through these focus areas , Boehringer Ingelheim can contribute to the creation of solutions for global challenges and help enable sustainable change . The impact in each area reflects its core business and aligns with the United Nations ’ Sustainable Development Goals ( SDGs ). Sustainable development goes hand-in-hand with the company ’ s planning principles of taking responsibility for communities and the environment .
Big Pharma has big aims and ambitions , providing a daily incentive for everyone working in the industry at every level . " We work to make humanity better , right ?" asks Rizzuti . " To make the lives of people and animals better every day . That ' s a difficult model to reject . It ' s definitely something that immediately gives you a sense of purpose when you ' re working in such an industry . It ' s a life science ; it ' s all about taking care of people , taking care of animals .” healthcare-digital . com 77